December, 27 2024 Friday 21:09 Hrs
  • SENSEX :   78,699.07

  • Commodity broking firm in India226.59( 0.29%) 27-Dec-2024
top-arrow-market
Sensex 78699.07 226.59  (0.29) 27-Dec-2024
Previous Day Close
78472.48
Today's High/Low
High Low
  •  
  •  
79043.15 78598.55

Profit and Loss

Zydus Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532321
INE010B01027
177.8674103
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ZYDUSLIFE
22.18
96553.18
EPS(TTM)
Face Value()
Div & Yield %
43.26
1
0.31
 
Particulars(INCOME)Mar 2024
( Cr)
Mar 2023
( Cr)
Mar 2022
( Cr)
Mar 2021
( Cr)
Mar 2020
( Cr)
Mar 2019
( Cr)
Sales Turnover 10818.708731.607836.907780.006347.406037.40
Excise Duty0.000.000.000.000.000.00
Net Sales10818.708731.607836.907780.006347.406037.40
Other Income 1084.80548.40178.7089.30908.70605.20
Stock Adjustments 131.70-105.1046.90148.30-15.5086.00
Total Income12035.209174.908062.508017.607240.606728.60
EXPENDITURE :
Raw Materials 3284.603066.202917.102499.701936.201950.20
Power & Fuel Cost298.20278.60245.20193.20208.40200.20
Employee Cost 1507.501321.901204.901147.301077.40961.20
Other Manufacturing Expenses 347.20332.50381.10363.40327.30347.00
Selling & Administrative Expenses 1016.001039.80958.401009.10925.30755.00
Miscellaneous Expenses 446.80336.90578.30594.40486.20280.00
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure6900.306375.906285.005807.104960.804493.60
Operating Profit5134.902799.001777.502210.502279.802235.00
Interest 390.70278.20134.9070.90233.9089.60
Gross Profit4744.202520.801642.602139.602045.902145.40
Depreciation504.40488.60478.70451.10428.90358.20
Profit Before Tax4239.802032.201163.901688.501617.001787.20
Tax934.30461.80260.20303.30164.10335.40
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-136.0041.2045.80-91.0040.00-33.90
Reported Net Profit3441.501529.20857.901476.201412.901485.70
Extraordinary Items 3.90-92.27-237.64-156.95-52.6774.44
Adjusted Net Profit3437.601621.471095.541633.151465.571411.26
Adjustment below Net Profit -54.001.80-6.90-15.30-6.00-294.40
P & L Balance brought forward10567.409289.408796.907336.006645.705812.70
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 607.30253.00358.500.00716.60358.30
P & L Balance carried down13347.6010567.409289.408796.907336.006645.70
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %300.00600.00250.00350.00350.00350.00
Dividend Per Share(Rs)3.006.002.503.503.503.50
Earnings Per Share-Unit Curr34.2115.118.3814.4213.8014.51
Earnings Per Share(Adj)-Unit Curr34.2115.118.3814.4213.8014.51
Book Value-Unit Curr156.23134.78129.30124.46109.9683.68
Book Value(Adj)-Unit Curr156.23134.78129.30124.46109.9683.68
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.